News Page: 1 of 4 Page: 1 2 3 4 Sort By Default Name Document Date Per Page 12 24 36 48 Items 25 to 36 of 48 total GE Healthcare expands cell therapy portfolio with license of STEMCELL Technologies’ T-Cell reagents 08/23/2016 STEMCELL Technologies Signs Exclusive Agreement with the Institute of Molecular Biotechnology to Commercialize Cerebral Organoid Culture Systems 04/13/2016 STEMCELL Technologies Will Test BioLife Solutions' evo™ Smart Shipper and Cloud Based biologistex™ Cold Chain Management App 01/06/2016 STEMCELL Technologies Inc. Obtains License from iPS Academia Japan for Induced Pluripotent Stem Cell Technologies 08/25/2015 Lawson and STEMCELL Technologies Announce Partnership for Commercialization of Tools for Parkinson's Disease Research 08/20/2015 STEMCELL Technologies Launches Innovative Products to Support CAR T Cell Research 06/30/2015 STEMCELL Technologies Named Company of the Year by BIOTECanada 06/11/2015 STEMCELL Technologies to Commercialize BrainPhys™ Neuronal Culture Medium for Improved Support of Neurophysiological Activity 05/05/2015 STEMCELL Technologies wins Support from Western Innovation (WINN) Initiative for Commercialization of 3D Cell Culture Platform 09/09/2014 STEMCELL Technologies Inc. has just released NEW MesenCult™ Proliferation Kit with MesenPure™ (Mouse), a novel cell culture medium to advance research on mouse mesenchymal stem and progenitor cells (MSCs) 05/09/2014 The HUB Foundation for Organoid Technology and STEMCELL Technologies Sign Agreement on the Manufacturing of Cell Culture Media for Organoids 01/21/2014 STEMCELL Technologies Receives Government of Canada Support to Develop New Cell Isolation Technology that will Enable Advancements in the Study of the Immune Response to HIV and the Development of HIV Vaccines 11/07/2013 Page: 1 of 4 Page: 1 2 3 4 Sort By Default Name Document Date Per Page 12 24 36 48 Items 25 to 36 of 48 total
